Christopher J Sobecki insider trades
Open-market stock purchases and sales by Christopher J Sobecki, Director at Lexicon Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 4, 2010.
Track record: 0% of 42 scored buys are up 5% or more since purchase, averaging -22%.
Get free alerts when Christopher J Sobecki files a new trade →